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Relationship between disseminated intravascular coagu-
lation and levels of plasma thrombinogen segment 1+2,
D-dimer, and thrombomodulin in patients with multiple
injuries
ZHU Yu-jun朱渝军*  and HUANG Xian-kai黄显凯
Objective:   To explore the relationship between dis-
seminated intravascular coagulation (DIC) and levels of
plasma thrombinogen segment 1+2 (F1+2), D-dimer (D-D),
and thrombomodulin (TM) in patients with severe multiple
injuries.
Methods:    In this study, 66 patients (49 males and 17
females, aged 15-74 years, mean=38.4 years) with multiple
injuries, who were admitted to our hospital within 24 hours
after injury with no personal or family history of hematopathy
or coagulopathy, were divided into a minor injury group
(ISS <16, n=21) and a major injury group (ISS≥16, n=45)
according to the injury severity. The patients in the major
injury group were divided into a  subgroup complicated
with DIC (DIC subgroup, n=12) and a subgroup compli-
cated with no DIC (non-DIC subgroup, n=33). Ten healthy
people (7 males and 3 females, aged 22-61 years, mean=36.5
years±9.0 years), who received somatoscopy and diagnosed
as healthy, served as the control group. Venous blood
samples were collected once in the control group and 1, 3
and 7 days after trauma in the injury groups. The F1+2 and
TM concentrations were determined by enzyme linked
immunosorbent assay (ELISA), and D-D concentrations
were measured by automated latex enhanced immunoassay.
Results:    F1+2, D-D and TM levels were higher in the
minor and major injury groups than in the control group.
They were markedly higher in the major injury group than in
the minor injury group. In the non-DIC subgroup, F1+2 levels
declined gradually while D-D and TM levels declined
continuously. In the DIC subgroup, F1+2 and D-D levels
remained elevated while TM levels exhibited an early rise
and subsequent decrease. Plasma F1+2, D-D and TM levels
were higher in the DIC patients than in the non-DIC patients.
Injury-induced increases in F1+2, D-D and TM plasma lev-
els had significant positive correlation with each other at
each time point.
Conclusions:    Besides being related to trauma severity,
F1+2, D-D and TM levels correlate closely with the occur-
rence of posttraumatic DIC. Therefore, changes in plasma
F1+2, D-D and TM levels may predict the occurrence of DIC.
Key words:    Multiple injuries; Disseminated intra-
vascular coagulation; Thrombomodulin
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Disseminated intravascular coagulation (DIC) ischaracterized by a widespread activation ofcoagulation, which results in the intravascular
formation of fibrin and ultimately thrombotic occlusion
of small and mid-sized vessels.1,2 DIC is associated
with a large variety of clinical disorders, among which
severe trauma is one of the most frequent clinical
precursors. Indeed, it is a common complication of
severe trauma with 50%-70% of severely injured pa-
tients presenting with this problem. 3
Findings from many years of basic researches and
clinical practice have provided a strong basis for under-
standing the pathophysiology of DIC.4,5 A variety of thera-
peutic measures have been developed to decrease DIC-
related mortalities. However, DIC-related mortalities re-
main unacceptably high for approximately 24.1%-80.8%.6
Coagulation involves the activation and interaction
of numerous molecules, including thrombinogen seg-
ment 1+2 (F1+2), D-dimer (D-D), and thrombomodulin
(TM). An upregulation in these factors may be a harbin-
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ger of impending DIC.  Reliable predictive biomarkers
of DIC may enable it to be prevented or treated earlier
in its pathogenic course, thus reducing DIC-related
mortality. Therefore, we examined whether the changes
in the plasma levels of F1+2, D-D, and/or TM corre-
lated with the incidence of DIC to explore the clinical
significance of these factors in patients with severe
multiple injuries in this study.
METHODS
General data of patients
The study cohort included 66 patients  (49 males
and 17 females, aged 15-74 years, mean=38.4 years)
with multiple injuries, who were admitted to our hospi-
tal within 24 hours after injury with no personal or fam-
ily history of hematopathy or coagulopathy, were di-
vided into a minor injury group (ISS<16, n=21) and a
major injury group (ISS≥16, n=45) according to the
injury severity. The general clinical data of patients are
summarized in Table 1. The patients in the major injury
group were divided into a  subgroup complicated with
DIC (DIC subgroup, n=12) and a subgroup complicated
with no DIC (non-DIC subgroup, n=33). Ten healthy
people (7 males and 3 females, aged 22-61 years,
mean=36.5 years±9.0 years),  who received
somatoscopy and diagnosed as healthy, served as the
control group.
Assaying methods
Peripheral venous blood samples were collected
once from the control subjects and 1, 3 and 7 days
after trauma from the injured patients. The blood speci-
mens were centrifugated at 1500 ×g for 15 minutes and
then immediately stored at -80°C. Plasma F1+2 and
TM concentrations were measured by Sandwich en-
zyme linked immunosorbent assay (ELISA, Dade-
Berring, Deerfield, IL, USA and Diaclone, Besancon
Cedex, France). Plasma D-D concentrations were mea-
sured by automated latex enhanced immunoassay kit
(Instrumentation Laboratory Corporation, Yaphank, NY,
USA).
Statistical analysis
All data were expressed as means ± standard de-
viation (SD) and subjected to Student’s t test.
Spearman’s correlation coefficients were used for cor-
relation analysis. A P value less than 0.05 was consid-
ered statistically significant in all cases.
RESULTS
Among the 66 patients with multiple injuries, 12 de-
veloped symptoms consistent with the diagnostic cri-
teria of DIC on the 4th day after injury. Among them, 6
patients died of respiratory and circulatory failures or
multiple organ failure (MOF), and the remaining 6 pa-
tients recovered without sequelae. All 54 patients in the
non-DIC subgroup recovered from their injuries (Table 1).
Changes of plasma F1+2, D-D, and TM levels in
patients with multiple injuries
The plasma levels of F1+2, D-D and TM 1, 3 and 7
days after injury are summarized in Table 2. Plasma
F1+2 levels were elevated markedly in both the minor
and the major injury groups on the 1st, 3rd and 7th
days after injury (P<0.01 compared with the healthy
controls). The plasma F1+2 levels decreased gradually
during the post-injury period in both groups, and the
decrease was more pronounced in the minor injury group
(P<0.05 in day-to-day comparisons). Plasma F1+2 lev-
els in the major injury group were higher than those of
the minor injury group (P<0.05) at every time point.
Plasma F1+2 levels did not differ significantly between
time points in the major injury subgroups (P>0.05).
As shown in Table 2, plasma D-D levels in the mi-
nor and major injury groups were elevated at all time
points (P<0.01, compared with the healthy controls).
In the minor injury group, plasma D-D levels showed a
modest (non-significant) increase between day 1 and
day 3 after injury and then decreased markedly from
day 3 to day 7 after injury (P<0.01). In the major injury
group, plasma D-D levels were not significantly differ-
ent from the healthy controls on day 1, but the increase
became significant on days 3 and 7 after injury (P<0.05,
compared with the healthy controls). The plasma D-D
levels in the major injury group were all significantly
higher than those in the minor injury group at every
time point (P<0.01).
Plasma TM levels were significantly higher in the
minor injury group than in the control group on day 1
after injury (P<0.05, Table 2). This effect dissipated over
time. On the 3rd day after injury, TM levels were similar
to those in the control group. Plasma TM levels were
higher in the major injury group than in the minor injury
and the control group at every time point (P<0.01).
Plasma TM levels in the major injury group showed a
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modest increase from day 1 to day 3 and decreased
markedly from day 3 to day 7 (P<0.01).
Relationship between DIC and changes in plasma
F1+2, D-D, and TM levels
The r and P values yielded by the statistical analy-
sis of the hypothesized relationships between the mo-
lecular data and the DIC occurrence data are presented
in Table 3.
Plasma F1+2 levels in the non-DIC subgroup gradu-
ally decreased, with levels becoming significantly dif-
ferent from the healthy controls on days 3 and 7 (P<0.01).
Meanwhile, plasma F1+2 levels in the DIC subgroup
persistently rose and manifested a clear difference from
the levels in non-DIC subgroup at every time point
(P<0.01). Plasma F1+2 levels on days 1, 3 and 7 after
injury had a positive relationship with the occurrence of
DIC (P<0.01).
As shown in Table 4, plasma D-D levels in the non-
DIC subgroup were consistently decreased on days 1,
3 and 7 after injury (P<0.01, compared with the healthy
controls), while plasma D-D levels in the DIC subgroup
were consistently increased (P< 0.01, compared with
the healthy controls). Plasma D-D levels differed be-
tween the two subgroups on days 3 and 7 after injury
(P<0.01). Furthermore, plasma D-D levels on days 1, 3
and 7 had a positive relationship with the occurrence of
DIC (P<0.01).
Plasma TM levels in the non-DIC subgroup de-
creased from day 1 to day 3 as well as from day 3 to
day 7 after injury (P<0.01, Table 4). Meanwhile, plasma
TM levels in the DIC subgroup rose from the 1st day to
the 3rd day after injury (P<0.01), and then decreased
sharply on day 7 (P<0.01, compared with the levels on
the 3rd day). Plasma TM levels in the DIC subgroup
remained significantly higher than those in the non-DIC
subgroup at all three time points (P<0.01). Plasma TM
levels on days 1, 3 and 7 had a positive relationship
with the occurrence of DIC (P<0.01).
DISCUSSION
Relationship between early changes in plasma
F1+2 levels and traumatic DIC
   F1+2 consists of  273 amino acids and its mo-
lecular weight is 5.8×10-23 kg. The active polypeptide
segment is generated when prothrombinase complex
converts prothrombin into its bioactive derivative
thrombin. Hence, increased F1+2 levels are often ac-
companied by thrombin formation and can be used to
assess thrombotic risk and monitor the efficacy of an-
ticoagulant therapy.7
The present study revealed marked increases in
plasma F1+2 levels in the minor and major injury groups
on days 1, 3 and 7 after injury. Higher F1+2 levels in
the major injury group than the minor injury group ob-
served at every time point indicated that patients with
more severe trauma were more likely to develop ex-
cess thrombosis, which may break the balance of co-
agulation and fibrinolysis. Indeed, more severely the
trauma is sustained, more intensely the blood coagu-
lation can be observed. Accordingly, higher F1+2 lev-
els with more severe injury are consistent with the sup-
position that F1+2 can serve as a direct marker of throm-
bin formation.
Three mechanisms are thought to lead to traumatic
DIC.8,9 The first mechanism is known as the extrinsic
pathway, that is, severe tissue injury exposes endot-
helial cells and monocytes to bacteria and pro-inflam-
matory cytokines, such as tumor necrosis factor-α
(TNF-α) and interleukin-1β (IL-1β), which induces
them to release tissue factor (TF). The released TF
forms the FVII-TF complex, which then stimulates the
coagulation cascade. The second mechanism is known
as the intrinsic pathway, that is, trauma-associated
ischemia, hypoxia and acidosis damage vascular en-
dothelial cells, exposing endomembraneous collagen,
which activates blood coagulation factor XII. Alternatively,
DIC may result from infection-associated trauma, es-
pecially Gram-negative bacterial infection. Bacterial en-
dotoxins induce mononuclear macrophages and neu-
trophi ls to release TNF-α, which results in
downregulation of TM expression in endothelial cells
and decreases the activity of activated protein C (APC),
ultimately facilitating coagulation.
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Increased plasma F1+2 levels in the patients with
severe multiple injuries indicate that the patients are in
a hypercoagulable state. In the non-DIC subgroup, we
observed that the plasma F1+2 levels were declined
when the patients’ conditions were alleviated and their
inflammation was controlled. Meanwhile in the DIC
subgroup, plasma F1+2 levels rose when the patients’
conditions were aggravated, coagulation pathology
progressed, and systemic inflammation became more
severe. Hence, the incipient concentration of F1+2 was
closely related with the incidence of DIC, and its dy-
namic tendency exactly reflected the change of coagu-
lation in the body. These observations confirmed that
F1+2 was a sensitive marker of coagulation.
Relationship between traumatic DIC and changes
in plasma D-D levels during an early stage of se-
vere multiple injuries
The pro-coagulent thrombin binds to the central
domain of fibrinogen and thereby releases Fibrinopep-
tides A and B, resulting in fibrin monomer and polymer
formation. The fibrin network is subsequently stabilized
(cross-linked) through its interaction with activated co-
agulation factor XIII. Fibrin degradation products such
as D-D are released when cross-linked fibrin networks
are lysed by plasmin.10 Thus D-D levels may reflect the
fibrin degradation and change in parallel with the pro-
duction of thrombin and plasmin. Plasma D-D levels
have been reported to be greatly elevated in hyperco-
agulable states and thrombosis.11 And D-D is generally
considered to be an important marker of fibrin produc-
tion and fibrinolysis activation.12 Furthermore, D-D is a
sensi tive and specif ic marker of  secondary
hyperfibrinolysis. Takagi et al13 discovered that D-D
plasma concentrations were elevated several days be-
fore the onset of clinical DIC. In light of such findings,
D-D is considered as one of the most valuable markers
in the diagnosis of DIC.14
In this study, plasma D-D levels in the minor injury
and major injury groups remained elevated throughout
the post-traumatic study period, and the levels in the
major injury group were significantly higher than those
of the minor injury group at every time point. These
findings suggested that all kinds of trauma patients,
especially the patients with severe multiple injuries,
readi l y dev eloped ex cess thrombosis and
hyperfibrinolysis, which led to abnormal coagulation.
Furthermore, higher D-D levels were observed with
greater trauma severity and presumably greater coagu-
lation and fibrinolysis. After injury, plasma D-D levels
decreased over time in the non-DIC subgroup but re-
mained increased in the DIC subgroup. The enduring
elevation of D-D levels in the DIC patients indicated that
the DIC patients had secondary fibrinolysis and persis-
tently aggravated coagulation. The positive relationship
between our plasma D-D data on days 1, 3 and 7 after
injury and the occurrence of DIC indicates that elevated
plasma D-D concentration has important clinical value in
terms of its ability to predict the occurrence of DIC earlily.
Relationship between traumatic DIC and changes
in plasma TM levels at an early stage of severe
multiple injuries
TM is a glycoprotein on the surface of vascular en-
dothelial cells. It is widely dispersed in the endothelial
tissues of blood and lymphatic vessels, especially in
the lungs, kidney and placenta.15 In addition to acceler-
ating thrombin-mediated activation of activated protein
C (APC) for anticoagulation and profibrinolysis, it also
inhibits thrombin activities, thereby having a direct ef-
fect on anticoagulation. Because TM is specifically dis-
tributed in vascular endothelial cells, it has been re-
garded as a molecular marker of vascular endothelial
injury in clinical studies of microangiopathy, cerebrovas-
cular disorders, cardiovascular diseases, diabetic
nephropathy, burn and tumor.
The thrombin-TM complex activates Protein C on
membrane-associated phospholipids. Thrombin bind-
ing to TM reduces the efficiency of thrombin catalysis
of procoagulant reactions.16 The mechanisms mediat-
ing the effects of TM include disruption of f ibrin
formation, inhibition of the activation of Factors V and
VIII, and inhibition of platelet aggregation and release.
TM can also degrade the plasminogen activator inhibi-
tor to promote fibrinolysis. TM has also been reported
to reduce the activation of prothrombin when it is com-
pounded with Factor Xa.17 Moreover, TM can clear away
the inactivated thrombin by receptor-mediated
endocytosis. Hence, overal l TM can decrease
thrombin’s effect through repressing the formation and
activity of thrombins.
   In this study, all patients with elevated plasma
TM levels suffered endothelial cell injury. Furthermore,
plasma TM levels were higher in the patients with ma-
jor injury than those with minor injury at every time point.
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These findings demonstrate that the severity of trauma
is closely related with the degree of endothelium
damage.
The presence of the anticoagulant factor TM is
closely related to the changes of coagulation/fibrinolysis.
TM levels are elevated in DIC patients because DIC
pathology involves vascular endothelium damage. The
observation of higher TM levels in DIC patients relative
to non-DIC patients is consistent with the supposition
that DIC pathology involves substantial vascular endot-
helium damage. Widespread and sustained endothe-
lial cell damage produces a homeostatic imbalance and
is thus accompanied by disruption of blood coagulation,
which results in DIC.18-20
Plasma TM levels on days 1, 3 and 7 after injury
had a positive relationship with the occurrence of DIC.
Importantly, TM levels were elevated before the clinical
diagnosis of DIC, which were earlier than prothrombin
time, activated partial thromboplastin time and platelet
abnormalities.21 Therefore, TM changes are clinically
important for predicting the occurrence of DIC at the
early stage.
Significance of changes in plasma F1+2, D-D and
TM levels in patients with multiple injuries
Fibrinolysis is a protective physiological reaction to
counteract coagulation through which fibrin clots are
dissolved and microcirculation is recovered. However,
excess fibrinolysis may increase the possibility of DIC
hemorrhage and can even cause recurrent bleeding.
Vascular endothelial cell is a multifunctional cell and
plays an important role in systemic protection, mate-
rial transportation and non-specific immunity. It also
has various regulation effects on hemorheology,
vasomotion, coagulation, anti-coagulation and
fibrinolysis.22 When vascular endothelium is damaged,
it releases TF triggering the extrinsic coagulation
pathway.
The fibrinolytic system is essential for blood
homeostasis. Endothelial cells synthesize tissue-type
plasminogen activator, urokinase-like plasminogen ac-
tivator and their respective receptors. Endothelial cells
synthesize plasminogen receptors, enabling them to
bind high concentrations of plasminogens secreted from
other cells. This plasminogen binding with endothelial
cells is very important for mainteinance of blood flow
through fibrinolysis.
  Coagulation, fibrinolysis and endothelial physiol-
ogy are three important inter-related factors in DIC.
Plasma F1+2, D-D and TM levels are elevated following
trauma, and higher levels following more severe trauma.
Our findings indicate that they can serve as beneficial
indices for predicting DIC at an early stage, especially
when assessed as a group.
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